MCP-1 is widely implicated in various diseases, including NASH, neuroinflammatory disorders, rheumatoid arthritis, cardiovascular diseases, and cancer, playing a role in attracting or enhancing the expression of other inflammatory factors and cells during these processes (40, 41). This evidence concerns the gene CCL2 and cancer.